Digital Content 
NEWS #PharmaBuzz
25 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immunic-presented-key-vidofludimus-calcium-data-at-the-41st-congress-of-ectrims-highlighting-its-potential-in-multiple-sclerosis-302566933.html
09 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for-united-states-patent-protecting-vidofludimus-calciums-dose-strengths-in-progressive-multiple-sclerosis-302550163.html
24 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immunic-reports-new-positive-long-term-open-label-extension-data-from-phase-2-emphasis-trial-of-vidofludimus-calcium-in-relapsing-remitting-multiple-sclerosis-302489105.html
05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immunic-announces-completion-of-enrollment-for-both-phase-3-ensure-trials-in-relapsing-ms-and-presents-additional-data-underlining-positive-outcome-of-phase-2-calliper-trial-in-progressive-ms-302474152.html
01 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/immunic-multiple-sclerosis-asset-misses-primary-endpoint-ph-2-trial-company-points-positive
26 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immunic-presents-key-vidofludimus-calcium-data-at-the-actrims-forum-2025-highlighting-its-potential-in-multiple-sclerosis-302385691.html
Share 